ReviewAdvances in experimental medicine and biology2026
Oral Innate Immunity and the Role of Oral Epithelial Cells.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Oral Barrier Immunometabolism in Chronic Low-Grade Inflammation: Molecular Mechanisms and Systemic Implications.International journal of molecular sciences · 2026Review
- Review
- Host-microbiome-immune disequilibrium in oral disease: mechanisms, dysbiosis, and precision therapeutics.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The oral mucosal epithelium is a complex structure that protects the underlying tissues from environmental exposure. Epithelial cells lining the mucosal surfaces of the oral cavity play an important role in innate immunity. They consist of stratified squamous epithelia that not only serve as a physical barrier but also contribute to innate immunity through the production of antimicrobial peptides and cytokines to prevent the invasion of oral pathogens. The oral cavity is constantly exposed to a great number of microorganisms. To fight against infection and maintain oral tissue homeostasis, the expression and function of cell surface receptors such as toll-like receptors (TLRs) are essential. TLRs belong to the family of pattern recognition receptors (PRRs) that recognize molecular structures categorized as "pathogen-associated molecular patterns" (PAMPs) present in microorganisms. Binding to TLRs triggers the activation of downstream signaling pathways and stimulates both innate and adaptive immune responses to suppress infection. Epithelial cells also engage distinct innate immune pathways that are implicated in the pathogenesis of oral cancer. The anticancer strategies of innate immunity include the development of an epithelial barrier, direct cytotoxicity, and presentation to various immune cells. Immune cells may have a dual impact by either promoting or suppressing cancer cell growth. Future research should investigate the factors that determine whether epithelial and immune cells promote or inhibit tumor growth. Although the mechanisms underlying this balance are not fully understood, enhancing innate immunity to combat oral infections and cancer holds potential as a strategy for early disease detection and improved treatment outcomes. Additionally, individual variations in host innate immune responses, contributing to oral cancer development, are another aspect of the complexity that requires further research.
Indexed as
Identifiers
41225091What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.